Clinical Trials Directory

Trials / Terminated

TerminatedNCT02717390

Bright by Three (BB3) Effectiveness Study

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
100 (actual)
Sponsor
University of Colorado, Denver · Academic / Other
Sex
All
Age
12 Months – 15 Months
Healthy volunteers
Accepted

Summary

The Investigators propose to conduct a pragmatic randomized controlled trial of 350 one to four year old children and their caregivers to study the effectiveness of 1) the Bright By Three (BB3) intervention for promoting children's language and socio-emotional development and 2) a modified version of the Safe 'N Sound (SNS) intervention for reducing safety hazards and injuries. The SNS intervention will serve as a control for the BB3 group and vice versa so that all study participants will receive a clinically meaningful intervention. In collaboration with primary care clinics that serve low-income and minority children, the Investigators will recruit and randomize 350 twelve to fifteen month olds and their parents/caregivers to one of the two intervention arms and deliver the interventions over a 2 year period.

Conditions

Interventions

TypeNameDescription
BEHAVIORALBright By Three (BB3)The purpose of the BB3 intervention (annual home visit, written materials, and BB3 mobile application 'app') is to increase parental talking, reading, playing, and praise (TRPP) behaviors and improves children's social-emotional and language development at ages 2, 3, and 4 years.
BEHAVIORALTexts for Child Safety (TCS)The purpose of the injury prevention arm is to reduce the prevalence of safety hazards in the home and car environments, decrease the number of self-reported and medically-attended injuries among children, and increase caregiver's self-reported safety behaviors and knowledge of child safety. The Investigators will compare the results of our tailored child safety intervention (Texts for Child Safety \[TCS\]) among participants in the injury prevention arm with those randomized to the BB3 arm.

Timeline

Start date
2017-08-01
Primary completion
2019-03-30
Completion
2019-03-30
First posted
2016-03-23
Last updated
2020-11-04

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02717390. Inclusion in this directory is not an endorsement.